Vincent Medical
Vincent Medical, a leading name in the medical device industry, is headquartered in Hong Kong and operates extensively across Asia and beyond. Founded in 2001, the company has established itself as a pioneer in the development of innovative respiratory and anaesthesia solutions, catering to the needs of healthcare professionals worldwide. Specialising in high-quality medical equipment, Vincent Medical offers a range of products, including advanced nebulisers and oxygen therapy devices, known for their reliability and user-friendly design. The company’s commitment to research and development has positioned it as a trusted partner in the healthcare sector, with notable achievements in enhancing patient care and safety. With a strong market presence and a reputation for excellence, Vincent Medical continues to lead the way in medical technology, striving to improve health outcomes globally.
DitchCarbon Score
How does Vincent Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vincent Medical's score of 35 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vincent Medical's reported carbon emissions
In 2024, Vincent Medical reported total carbon emissions of approximately 5,651,160 kg CO2e, a significant decrease from about 7,210,800 kg CO2e in 2023. The emissions breakdown for 2024 includes Scope 1 emissions of about 62,850 kg CO2e, Scope 2 emissions of approximately 5,353,760 kg CO2e, and Scope 3 emissions of about 92,150 kg CO2e. This reflects a continued commitment to reducing their carbon footprint, although specific reduction targets have not been disclosed. In 2023, the company’s emissions were primarily driven by Scope 2, which accounted for about 6,761,370 kg CO2e, while Scope 1 and Scope 3 emissions were significantly lower. The trend shows a gradual reduction in total emissions from about 12,315,000 kg CO2e in 2022 and 12,855,000 kg CO2e in 2021, indicating a positive trajectory towards sustainability. Vincent Medical's emissions data is cascaded from its parent company, Vincent Medical Holdings Limited, which provides a comprehensive overview of the organisation's climate impact. Despite the absence of specific reduction initiatives or targets, the company is actively monitoring and reporting its emissions across all three scopes, demonstrating a commitment to transparency and accountability in its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 14,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 10,855,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 231,000 | 000,000 | 0,000 | 0,000 | 00,000 | 00,000 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vincent Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
